[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366326-105":59,"doc-detail-366326-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hsa-mirna-16-5p-of-urinary-exosomes-a-reliable-biosignature-effective-for-prostate-cancer-screening","Hsa-miRNA-16-5p Of Urinary Exosomes - A Reliable Biosignature Effective For Prostate Cancer Screening","","A simple, rapid, and cost-effective reagent for exosomal microRNA extraction from urine is evaluated for prostate cancer screening. Using polyethylene glycol (PEG), sodium dodecyl sulfate (SDS), and diethyl pyrocarbonate (DEPC), miRNAs were extracted and quantified by RT-qPCR, focusing on hsa-miR-16-5p (miR-16) with miR-21 as a reference. In a cohort of 39 clinical samples, miR-16 expression differed across prostate cancer stages and distinguished cancerous from non-cancerous individuals. Receiver operating characteristic analysis supports diagnostic value, with performance comparable to commercial kits.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hsa-mirna-16-5p-of-urinary-exosomes-a-reliable-biosignature-effective-for-prostate-cancer-screening/366326/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hsa-mirna-16-5p-of-urinary-exosomes-a-reliable-biosignature-effective-for-prostate-cancer-screening/366326.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarker is evaluated for prostate cancer screening in this study?","Question",{"text":112,"@type":113},"The study evaluates hsa-miR-16-5p (miR-16) as a promising diagnostic biomarker derived from urinary exosomes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were urinary exosomes and miRNAs processed and measured?",{"text":117,"@type":113},"Urinary exosomal miRNAs were extracted using a PEG/SDS/DEPC-based reagent and validated with RT-qPCR, comparing performance against commercial kits.",{"name":119,"@type":110,"acceptedAnswer":120},"What samples were analyzed and how was diagnostic performance assessed?",{"text":121,"@type":113},"A cohort of 39 samples (28 prostate cancer patients, 1 BPH case, and 10 healthy controls) was analyzed, with statistical comparisons using T-tests and diagnostic value assessed by ROC analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366326,1790212156,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","International Journal of Nanomedicine  \nOpen Access Full Text Article ORIGINAL RESEARCH  \nHsa-miRNA-16-5p Of Urinary Exosomes A Reliable Biosignature Effective For Prostate Cancer Screening  \nWen-Hui Weng 1 , Yueh-Er Chiou2 , Wen-Zhen Zeng 1 , Ming-Hui Chen 1 , See-Tong Pang 3  \n1Department of Chemical Engineering and Biotechnology and Graduate Institute of Biochemical and Biomedical Engineering, National Taipei University of Technology, Taipei City, Taiwan; 2Department of Nursing, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan; 3Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, LinKou Branch, Taoyuan, Taiwan  \nCorrespondence: See-Tong Pang, Division of Urology, Department of Surgery, Chang Gung Memorial Hospital, LinKou Branch, No. 5, Fuxing Street, Guishan District, Taoyuan, 33305, Taiwan, Tel +886-3-3281200, Email [jacobpang@cgmh.org.tw](jacobpang@cgmh.org.tw)  \n\n| Introduction: MicroRNAs (miRNAs) are small, non-coding RNA molecules critical for cellular function, growth, and development. Recent advances in remote diagnostic technologies have highlighted the potential of urinary miRNAs as non-invasive biomarkers for disease monitoring. This study introduces a simple, rapid, and cost-effective reagent for exosomal miRNA extraction, designed for urine-based exosome screening. We further identified hsa-miR-16-5p (miR-16) as a promising diagnostic biomarker for prostate cancer (PCa), with the goal of integrating this method with biosensors to enable rapid result acquisition and support early cancer detection and treatment planning.\u003Cbr>Materials and Methods: The extraction reagent was formulated using polyethylene glycol (PEG), sodium dodecyl sulfate (SDS), and diethyl pyrocarbonate (DEPC), differing from commercial kits. miRNAs were extracted and validated through RT-qPCR, focusing on miR-16 and the reference control miR-21 . Results were compared against commercial kits. A cohort of 39 clinical samples—28 PCa patients, 1 benign prostatic hyperplasia (BPH) case, and 10 healthy controls (Ctr)—was analyzed. Statistical evaluations included T-tests and receiver operating characteristic (ROC) analysis to assess the diagnostic value of miR-16 .\u003Cbr>Results: miR-16 expression significantly differed across PCa stages and between cancerous and non-cancerous individuals (Ctr vs Stage IV: p \u003C 0.05; Stage II vs III: p \u003C 0.05; Stage II vs IV: p \u003C 0.005; Stage III vs IV: p \u003C 0.05) . ROC analysis confirmed miR-16’s diagnostic potential, particularly in detecting mid-stage PCa.\u003Cbr>Conclusion: The proposed extraction method matches commercial kits in performance but offers notable advantages: a simplified five-step process, reduced extraction time (1 .08 hours), and low cost ($0 . 13/test) . These findings support the use of urinary miR-16 asa biomarker for PCa staging and highlight the practical value of the newly developed extraction reagent.\u003Cbr>Keywords: exosome extraction, urine miR-16, prostate cancer, diagnosis |\n| --- |\n| Introduction\u003Cbr>In modern clinical medicine, urine—alongside blood—is one of the most widely utilized non-invasive biological fluids for diagnostic purposes. Particularly in the context of remote medical monitoring and cellular microenvironment analysis, urine offers a convenient, relatively contamination-free, and reliable specimen. Compared to other biological fluids such as saliva, sweat, breast milk, and feces, urine provides distinct advantages in terms of collection ease and diagnostic consistency. Humans typically excrete approximately 1–2 liters of urine per day. A major advantage of using urine over other biological fluids is its ease of collection, allowing for frequent and large-volume sampling without the need for specialized equipment or technical expertise.1–3 It is well established that many cancer-related miRNA biomarkers are encapsulated within urinary exosomes. The bilayer lipid membrane of these exosomes protects the miRNAs from degradation, thereby en","cbCaiaOA2qhLaIRF","https://ap.wps.com/l/cbCaiaOA2qhLaIRF","pdf",2423162,"English","# Introduction\n## Materials and Methods\n## Results\n## Conclusion\n## Keywords","[{\"question\":\"What biomarker is evaluated for prostate cancer screening in this study?\",\"answer\":\"The study evaluates hsa-miR-16-5p (miR-16) as a promising diagnostic biomarker derived from urinary exosomes.\"},{\"question\":\"How were urinary exosomes and miRNAs processed and measured?\",\"answer\":\"Urinary exosomal miRNAs were extracted using a PEG/SDS/DEPC-based reagent and validated with RT-qPCR, comparing performance against commercial kits.\"},{\"question\":\"What samples were analyzed and how was diagnostic performance assessed?\",\"answer\":\"A cohort of 39 samples (28 prostate cancer patients, 1 BPH case, and 10 healthy controls) was analyzed, with statistical comparisons using T-tests and diagnostic value assessed by ROC analysis.\"}]","Hsa-miRNA-16-5p Of Urinary Exosomes - A Reliable Biosignature Effective For Prostate Cancer Screening | PDF",1790164819,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/77abcef1cd77d5c8c73cfc8fad96d604.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eca57f2498e59e21664ab68e0a51e7c5.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b73232f5210e32c34b5d1133e957c3db.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73b7347db767531452de1a393e642892.webp",980,1268]